These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4172818)

  • 1. Treating drug-addiction.
    Fink M; Freedman AM
    Lancet; 1968 Jun; 1(7554):1256. PubMed ID: 4172818
    [No Abstract]   [Full Text] [Related]  

  • 2. Basic concepts and use of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M
    Br J Addict Alcohol Other Drugs; 1968 Sep; 63(1):59-69. PubMed ID: 5245946
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies of cyclazocine in the treatment of narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    Am J Psychiatry; 1968 May; 124(11):1499-504. PubMed ID: 4869436
    [No Abstract]   [Full Text] [Related]  

  • 4. Narcotic antagonists: new methods to treat heroin addiction.
    Hammond AL
    Science; 1971 Aug; 173(3996):503-6. PubMed ID: 5564039
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of cyclazocine in the treatment of heroin addicts.
    Petursson ES; Preble E
    Dis Nerv Syst; 1970 Aug; 31(8):549-51. PubMed ID: 5471792
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of drugs in the management of drug dependence.
    Eddy NB
    J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204
    [No Abstract]   [Full Text] [Related]  

  • 7. Narcotic antagonists in opiate dependence.
    Fink M
    Science; 1970 Sep; 169(3949):1005-6. PubMed ID: 4914724
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclazocine and methadone in narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
    [No Abstract]   [Full Text] [Related]  

  • 9. XXIX. The basis and possible utility of the use of opioid antagonists in the ambulatory treatment of the addict.
    Martin WR
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():367-77. PubMed ID: 5723804
    [No Abstract]   [Full Text] [Related]  

  • 10. A cyclazocine typology in opiate dependence.
    Resnick RB; Fink M; Freedman AM
    Am J Psychiatry; 1970 Mar; 126(9):1256-60. PubMed ID: 5413202
    [No Abstract]   [Full Text] [Related]  

  • 11. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
    Martin WR
    NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy of narcotic dependence.
    Maykut MO
    Prog Neuropsychopharmacol; 1977; 1(1-2):31-49. PubMed ID: 31641
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological adjuncts in the treatment of opiate dependence.
    Resnick RB
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
    [No Abstract]   [Full Text] [Related]  

  • 14. Narcotic antagonists: naltrexone progress report: foreword.
    Jaffe J
    NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
    [No Abstract]   [Full Text] [Related]  

  • 15. New trends in narcotic addiction control.
    Hess CB
    Public Health Rep (1896); 1966 Mar; 81(3):277-81. PubMed ID: 4956001
    [No Abstract]   [Full Text] [Related]  

  • 16. Opiate antagonists and 'blockers'.
    Murphree HB
    Am Fam Physician; 1973 Apr; 7(4):136-7. PubMed ID: 4694336
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclazocine in the treatment of narcotic addiction.
    Jaffe JH
    Curr Psychiatr Ther; 1967; 7():147-56. PubMed ID: 4860298
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclazocine treatment of opiate dependence: a progress report.
    Resnick RB; Fink M; Freedman AM
    Compr Psychiatry; 1971 Nov; 12(6):491-502. PubMed ID: 5117068
    [No Abstract]   [Full Text] [Related]  

  • 19. Human pharmacology of narcotic antagonists.
    Jasinski DR
    Br J Clin Pharmacol; 1979; 7 Suppl 3(Suppl 3):287S-290S. PubMed ID: 465291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design consideration for long-acting antagonists.
    Archer S
    Adv Biochem Psychopharmacol; 1973; 8(0):549-53. PubMed ID: 4368570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.